Relationship between anxiety, depression and CD4+ T lymphocytes in patients with Human Immunodeficiency Virus (HIV) in a general hospital in Lima

Authors

DOI:

https://doi.org/10.20453/rnp.v86i3-1.4972

Keywords:

Anxiety, depression, CD4 T lymphocyte, HIV infections, Peru

Abstract

Objective: To determine the relationship between anxiety, depression and CD4+ T lymphocyte count in a sample of people carrying the human immunodeficiency virus (HIV). Methodology: Observational and analytical study. A total of 144 HIV-positive patients were evaluated. The Hospital Anxiety and Depression Scale (HADS) was used. Results: The sample’s mean age was 41 years. Most of the probands were male (71.5%), single (86.1%) and with secondary education (57.6%). The average length of the disease was 7.7 years, 11.1% presented some comorbidity, and 95.1% used tenofovir as treatment. Thirty-four and 16.7% presented some level of anxiety and depression, respectively. Patients at the AIDS stage presented higher levels of anxiety (p < 0.001) and depression (p < 0.001).
Patients with HIV and medical comorbidities had higher levels of depression (p = 0.044). Anxiety (ρ = -0.516, p = 0.01) and depression (ρ = -0.509; p = 0.01) levels were related to CD4+ T lymphocyte count. Conclusion: Higher levels of depression were found in patients with comorbidities and AIDS stage, and higher levels of anxiety were found in patients at the AIDS stage. In addition, a significant indirect relationship was found between anxiety and depression levels and the CD4+ T cell count. Training healthcare professionals to screen for anxiety and depressionin order to improve the mental health of HIV patients, is highly recommended.

Downloads

Download data is not yet available.

References

Organización Mundial de la Salud. VIH y SIDA [Internet]. OMS: 2023, 13 de julio. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/hiv-aids

Millán IC, Romero D, Estrada-Orozco K. Efectividad y seguridad de antirretrovirales para terapia de cambio en virus de la inmunodeficiencia humana. Rev Cubana Med Trop [Internet]. 2021; 73(3): e642. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0375-07602021000300012

Centro Nacional de Epidemiología Prevención y Control de Enfermedades. Situación epidemiológica del VIH-sida en el Perú [Internet]. Lima: CDC Minsa; 2021. Boletín VIH, febrero 2021. Disponible en: https://www.dge.gob.pe/portal/docs/vigilancia/vih/Boletin_2021/febrero.pdf

Centro Nacional de Epidemiología Prevención y Control de Enfermedades. Situación epidemiológica del VIH-sida en el Perú [Internet]. Lima: CDC Minsa; 2023. Disponible en: https://www.dge.gob.pe/vih/uploads/nacional_vih.html.

Khare RL, Rajpoot V, Dubey S. Evaluation of depression and anxiety and its association with CD4 count among HIV patients taking antiretroviral therapy. J Evol Med Dent Sci [Internet]. 2020; 9(31): 2223-2227. Disponible en: https://www.researchgate.net/publication/343504209_Evaluation_of_Depression_and_Anxiety_and_Its_Association_with_CD4_Count_among_HIV_Patients_Taking_Antiretroviral_Therapy

Grupo de Estudio del SIDA-SEIMC (GeSIDA). Documento de consenso de GeSIDA/Plan nacional sobre el SIDA respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana [Internet]. Madrid: Ministerio de Sanidad, Consumo y Bienestar Social; 2020. Disponible en: https://gesida-seimc.org/wp-content/uploads/2020/07/TAR_GUIA_GESIDA_2020_COMPLETA_Julio.pdf

Rehm KE, Konkle-Parker D. Association of CD4+ T cell subpopulations and psychological stress measures in women living with HIV. AIDS Care [Internet]. 2017; 29(9): 1107-1111. Disponible en: https://www.tandfonline.com/doi/abs/10.1080/09540121.2017.1281880

Agus DF, Effendy E, Camellia V. Screening of anxiety and depression related CD4 count of people living with HIV/AIDS with anti-retroviral in Medan, Indonesia. Open Access Maced J Med Sci [Internet]. 2019; 7(16): 2590-2594. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876798/

Parcesepe AM, Bernard C, Agler R, Ross J, Yotebieng M, Bass J, et al. Mental health and HIV: research priorities related to the implementation and scale up of 'treat all' in sub-Saharan Africa. J Virus Erad [Internet]. 2018; 4(Supl. 2): 16-25. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248852/

Canales-Zavala MA, Hernández-Ruiz AV, González-Venegas S, Monroy-Avalos AC, Velázquez-Camarillo AA, Bautista-Díaz ML. Calidad de vida, sintomatología de ansiedad y depresión en personas con VIH: el papel del psicólogo de la salud. Educ Salud Bol Científico Inst Cienc Salud Univ Autónoma Estado Hidalgo [Internet]. 2019; 8(15): 80-91. Disponible en: https://repository.uaeh.edu.mx/revistas/index.php/ICSA/article/view/4829

Moraes RP, Casseb J. Depression and adherence to antiretroviral treatment in HIV-positive men in São Paulo, the largest city in South America: social and psychological implications. Clinics (Sao Paulo) [Internet]. 2017; 72(12): 743-749. Disponible en: https://chooser.crossref.org/?doi=10.6061%2Fclinics%2F2017%2812%2905

El-Halabi S, Cooper DH, Cha DS, Rosenblat JD, Gill B, Rodrigues NB, et al. The effects of antidepressant medications on antiretroviral treatment adherence in HIV-positive individuals with depression. J Affect Disord [Internet]. 2022; 300: 219-225. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0165032721013884?via%3Dihub

Caycho T, Ventura J, Reyes M, Noe M, Barboza M, Peña B, et al. Evidencia preliminar de la validez y fiabilidad de una medida breve del impacto de la ansiedad en la salud de pacientes con VIH. Ansiedad y Estrés [Internet]. 2021; 27(2): 123-131. Disponible en: https://www.ansiedadyestres.es/art/2021/anyes2021a17

Chibanda D, Benjamin L, Weiss HA, Abas M. Mental, neurological, and substance use disorders in people living with HIV/AIDS in low- and middle-income countries. J Acquir Immune Defic Syndr [Internet]. 2014; 67(Supl. 1): S54-S67. Disponible en: https://journals.lww.com/jaids/fulltext/2014/09011/mental,_neurological,_and_substance_use_disorders.7.aspx

Trujillo JJ. Niveles de ansiedad y depresión en pacientes con VIH/SIDA del programa TARGA del Hospital Regional Germilio Valdizán Huánuco-2017 [tesis de licenciatura en internet]. Huánuco: Universidad de Huánuco; 2019. Disponible en: http://repositorio.udh.edu.pe/123456789/1746

Girma D, Assegid S, Gezahegn Y. Depression and associated factors among HIV-positive youths attending antiretroviral therapy clinics in Jimma town, southwest Ethiopia. PLoS One [Internet]. 2021; 16(1): e0244879. Disponible en: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0244879

Maldonado H, Peña RF, Tomateo J. Frecuencia de episodio depresivo mayor y factores relacionados en pacientes infectados por el virus de la inmunodeficiencia humana en tratamiento antirretroviral de gran actividad (TARGA) en un hospital público de Lima. Rev Neuropsiquiatr [Internet]. 2015; 78(1): 3-13. Disponible en: https://revistas.upch.edu.pe/index.php/RNP/article/view/2355

Ministerio de Salud. Repositorio Único Nacional de Información en Salud - REUNIS [Internet]. Lima: Minsa; 2023. Disponible en: https://www.minsa.gob.pe/reunis/data/dgos_monitoreo_gestion.asp

Gobierno del Perú. Servicio de Infectología: 17 años trabajando por sus pacientes de forma continua [Internet]. Lima: Gobierno del Perú; 2022, 19 de febrero. Disponible en: https://www.gob.pe/institucion/hospitalloayza/noticias/585032-servicio-de-infectologia-17-anos-trabajando-por-sus-pacientes-de-forma-continua

Madrigal AV, Pablo MG, Flores J, Urdapilleta E, Lara G, Galindo Ó. Propiedades psicométricas de la Escala de Ansiedad y Depresión Hospitalaria (HADS) en una muestra de pacientes mexicanos con enfermedades respiratorias. Psicol Salud [Internet]. 2021; 31(2): 323-332. Disponible en: https://psicologiaysalud.uv.mx/index.php/psicysalud/article/view/2700

Patilla C. Adaptación de la escala hospitalaria de ansiedad y depresión (HAD) en una muestra de pacientes con cáncer de mama. Temática Psicológica [Internet]. 2018; 14(1): 69-75. Disponible en: https://revistas.unife.edu.pe/index.php/tematicapsicologica/article/view/1811

Hurtado JM. Asociación entre depresión e inmunosupresión en pacientes con VIH en un hospital regional-Junín 2018 [Tesis de licenciatura en internet]. Huancayo: Universidad Peruana Los Andes; 2020. Disponible en: https://hdl.handle.net/20.500.12848/1320

Chen S, Hong H, Xu G. Prevalence and related factors of depressive symptoms among HIV/AIDS in Ningbo, China: a cross-sectional study. Front Psychiatry [Internet]. 2022; 13: 1004318. Disponible en: https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1004318/full

Olatayo A, Usman M, Olusesan J. Prevalence of depression and anxiety disorders in people living with HIV/AIDS in a tertiary Hospital in South Western Nigeria. Med Rep Case Stud [Internet]. 2018; 3(1): 1-5. Disponible en: https://www.iomcworld.org/open-access/prevalence-of-depression-and-anxiety-disorders-in-people-living-with-hivaids-in-a-tertiary-hospital-in-south-western-nigeria-2572-5130-1000150.pdf

Rezaei S, Ahmadi S, Rahmati J, Hosseinifard H, Dehnad A, Aryankhesal A, et al. Global prevalence of depression in HIV/AIDS: a systematic review and meta-analysis. BMJ Support Palliat Care [Internet]. 2019; 9(4): 404-412. Disponible en: https://spcare.bmj.com/content/9/4/404

Arseniou S, Arvaniti A, Samakouri M. HIV infection and depression. Psychiatry Clin Neurosci [Internet]. 2014; 68(2): 96-109. Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/pcn.12097

Havlik RJ, Brennan M, Karpiak SE. Comorbidities and depression in older adults with HIV. Sex Health [Internet]. 2011; 8(4): 551-559. Disponible en: https://www.publish.csiro.au/sh/SH11017

Reis RK, Santos E, De Castro C, Gimeniz MT, Toffano-Malaguti SE, Gir E. Prevalence and factors associated with depressive symptoms in individuals living with HIV/AIDS. Salud Ment [Internet]. 2017; 40(2): 57-62. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=72335

Tlacuilo Y. Depresión y niveles de CD4 en pacientes con VIH/SIDA de la UMF 2 [tesis de licenciatura en internet]. Puebla: Benemérita Universidad Autónoma de Puebla; Instituto Mexicano del Seguro Social; 2019. Disponible en: https://hdl.handle.net/20.500.12371/11298

Yousuf A, Musa R, Isa ML, Arifin SRM. Anxiety and depression among women living with HIV: prevalence and correlations. Clin Pract Epidemiol Ment Health [Internet]. 2020; 16: 59-66. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372730/

Shi Y, Yang C, Xu L, He Y, Wang H, Cao J, et al. CD4+ T cell count, sleep, depression, and anxiety in people living with HIV: a growth curve mixture modeling. J Assoc Nurses AIDS Care [Internet]. 2020; 31(5): 535-543. Disponible en: https://journals.lww.com/janac/fulltext/2020/10000/cd4__t_cell_count,_sleep,_depression,_and_anxiety.6.aspx

Checa A, Navas E, Valencia V, Alcívar J. Asociación entre conteo de CD4 y depresión en personas que viven con VIH en Ecuador. Rev Mex Neurocienc [Internet]. 2021; 22(6): 224-228. Disponible en: https://www.revmexneurociencia.com/frame_esp.php?id=159

Published

2023-10-03

How to Cite

1.
Grados-Castro D, Huarcaya-Victoria J. Relationship between anxiety, depression and CD4+ T lymphocytes in patients with Human Immunodeficiency Virus (HIV) in a general hospital in Lima. Rev Neuropsiquiatr [Internet]. 2023 Oct. 3 [cited 2025 Dec. 7];86(3):171-80. Available from: https://revistas.upch.edu.pe/index.php/RNP/article/view/4972

Issue

Section

ORIGINAL ARTICLE

Most read articles by the same author(s)